Dr. Prakash Chinnaiyan, MD

Dr. Chinnaiyan practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Chinnaiyan's NPI, 1467402172, was assigned on May 11, 2006. Dr. Chinnaiyan graduated from Wayne State University School of Medicine in 2000. Dr. Chinnaiyan holds Michigan license 4301106591.

Dr. Chinnaiyan's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Chinnaiyan's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Chinnaiyan is also affiliated with Corewell Health Beaumont Troy Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Chinnaiyan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chinnaiyan practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Chinnaiyan's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Chinnaiyan's licenses on file in 2 states: Michigan and Wisconsin.

CMS data shows 585 Medicare services from Dr. Chinnaiyan across 8 procedure codes in 2024, for 108 Medicare patients. Medicare paid $31,474 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 108 Medicare patients who saw Dr. Chinnaiyan in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have high blood pressure, and 64% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chinnaiyan's median patient age at 60, with 46% women.

In 2023, Dr. Chinnaiyan wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $475 in total drug cost. In 2022, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Chinnaiyan for performance year 2024, reported as part of a group. Dr. Chinnaiyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 49 papers to Dr. Chinnaiyan, published from 2008 to 2025. 2022 was the busiest year, with 4. The most frequent topics are Brain Neoplasms, Glioblastoma and Cell Line, Tumor. Dr. Chinnaiyan has published most often in Neuro Oncol. Dr. Chinnaiyan's most frequent co-authors are Inga Siiner Grills, Kamran Ali Ahmed, MD and Peter Chen, MD.

Dmand AI links Dr. Chinnaiyan to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Brain Neoplasms, Glioblastoma and Astrocytoma.

CMS Open Payments shows 8 general payments to Dr. Chinnaiyan from 6 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 65% of the total. Novocure Inc. paid the most, $1,361.

Dr. Chinnaiyan graduated from Wayne State University School of Medicine in 2000.